Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: Results from a large patient cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 3, 2015, Pages E531-E541

  Dénes, Judit ^a,b   Swords, Francesca ^c   Rattenberry, Eleanor ^d   Stals, Karen ^e   Owens, Martina ^e   Cranston, Treena ^g   Xekouki, Paraskevi ^h   Moran, Linda ⁱ   Kumar, Ajith ^j   Wassif, Christopher ^h   Fersht, Naomi ^k   Baldeweg, Stephanie E ^k   Morris, Damian ^l   Lightman, Stafford ^m   Agha, Amar ⁿ   Rees, Aled ^o   Grieve, Joan ^p   Powell, Michael ^p   Boguszewski, Cesar Luiz ^q   Dutta, Pinaki ^r   Thakker, Rajesh V ^s   Srirangalingam, Umasuthan ^a   Thompson, Chris J ⁿ   Druce, Maralyn ^a   Higham, Claire ^t   Davis, Julian ^u,v   Eeles, Rosalind ^w   Stevenson, Mark ^s   O'Sullivan, Brendan ^x   Taniere, Phillipe ^x   Skordilis, Kassiani ^x   Gabrovska, Plamena ^a   Barlier, Anne ^y   Webb, Susan M ^z,aa   Aulinas, Anna ^z,aa   Drake, William M ^a   Bevan, John S ^ab   Preda, Cristina ^ac   Dalantaeva, Nadezhda ^ad   Ribeiro Oliveira, Antônio ^ae   Garcia, Isabel Tena ^af   Yordanova, Galina ^ag   Iotova, Violeta ^ag   Evanson, Jane ^ah   Grossman, Ashley B ^ai   Trouillas, Jacqueline ^aj   Ellard, Sian ^e,f   Stratakis, Constantine A ^h   Maher, Eamonn R ^d,ak   Roncaroli, Federico ^al   Korbonits, Márta ^a   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^g CHURCHILL HOSPITAL   (United Kingdom)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ CHARING CROSS HOSPITAL   (United Kingdom)

^j GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^k UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^l IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^m UNIVERSITY OF BRISTOL   (United Kingdom)

ⁿ BEAUMONT HOSPITAL   (Ireland)

^o CARDIFF UNIVERSITY   (United Kingdom)

^p NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^q FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^r POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^s UNIVERSITY OF OXFORD   (United Kingdom)

^t CHRISTIE HOSPITAL   (United Kingdom)

^u UNIVERSITY OF MANCHESTER   (United Kingdom)

^v MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^w INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^x UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^y AIX MARSEILLE UNIVERSITY   (France)

^z INSTITUTO DE SALUD CARLOS III   (Spain)

^aa UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^ab ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^ac GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^ad MOSCOW STATE UNIVERSITY   (Russian Federation)

^ae FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^af HOSPITAL PROVINCIAL DE CASTELLÓN   (Spain)

^ag UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

^ah ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^ai UNIVERSITY OF OXFORD   (United Kingdom)

^aj UNIVERSITÉ DE LYON   (France)

^ak UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^al IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIP GENE; ARTICLE; CDKN1B GENE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FH GENE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; MALE; MEN1 GENE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RET GENE; SDHA D GENE; SDHAF2 GENE; TMEM127 GENE; VHL GENE; ADENOMA; ADRENAL GLAND NEOPLASMS; COHORT ANALYSIS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PARAGANGLIOMA; PITUITARY NEOPLASMS; YOUNG ADULT;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PITUITARY NEOPLASMS; YOUNG ADULT;

EID: 84924973484     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3399     Document Type: Article

References (52)

1. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab. 2006;91:4769-4775.
2. Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010;72:377-382.
3. Mazzaglia PJ. Hereditary pheochromocytoma and paraganglioma. J Surg Oncol. 2012;106:580-585.
4. Eisenhofer G, Pacak K, Maher ER, Young WF, de Krijger RR. Pheochromocytoma. Clin Chem. 2013;59:466-472.
5. Iversen K. Acromegaly associated with phaeochromocytoma. Acta Med Scand. 1952;142:1-5.
6. Beckers A. Means, motive, and opportunity: SDH mutations are suspects in pituitary tumors. J Clin Endocrinol Metab. 2013;98:2274-2276.
7. Xekouki P, Stratakis CA. Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects? Endocr Relat Cancer. 2012;19:C33-C40.
8. Dwight T, Mann K, Benn DE, et al. Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. J Clin Endocrinol Metab. 2013;98:E1103-E1108.
9. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81-88.
10. Korbonits M, Storr H, Kumar AV. Familial pituitary adenomas - who should be tested for AIP mutations? Clin Endocrinol (Oxf). 2012;77:351-356.
11. Owens M, Stals K, Ellard S, Vaidya B. Germline mutations in the CDKN1B gene encoding p27 Kip1 are a rare cause of multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2009;70:499-500.
12. Occhi G, Regazzo D, Trivellin G, et al. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genet. 2013;9:e1003350.
13. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30:e57.
14. Rattenberry E, Vialard L, Yeung A, et al. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2013;98:E1248-E1256.
15. th century and today. N Engl J Med. 2011;364:43-50.
16. Sassolas G, Chayvialle JA, Partensky C, et al. [Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors]. Ann Endocrinol (Paris). 1983;44:347-354.
17. Berger G, Trouillas J, Bloch B, et al. Multihormonal carcinoid tumor of the pancreas. Secreting growth hormone-releasing factor as a cause of acromegaly. Cancer. 1984;54:2097-2108.
18. Harding B, Lemos MC, Reed AA, et al. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia. Endocr Relat Cancer. 2009;16:1313-1327.
19. Gill AJ, Benn DE, Chou A, et al. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol. 2010;41:805-814.
20. Tudorancea A, Francois P, Trouillas J, et al. Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy. Ann Endocrinol (Paris). 2012;73:37-42.
21. Mumby C, Davis JR, Trouillas J, Higham CE. Phaeochromocytoma and acromegaly: a unifying diagnosis. Endocrinol Diabetes Metab Case Rep. 2014;2014:140036.
22. OngKR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat. 2007;28:143-149.
23. Langer P, Cupisti K, Bartsch DK, et al. Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg. 2002;26:891-896.
24. Dackiw AP, Cote GJ, Fleming JB, et al. Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery. 1999;126:1097-1103; discussion 1103-1104.
25. Jamilloux Y, Favier J, Pertuit M, et al. A MEN1 syndrome with a paraganglioma. Eur J Hum Genet. 2014;22:283-285.
26. Herincs M, Owusu-Antwi S, Chahal HS, et al. Prevalence of familial isolated pituitary adenomas. Endocrine Abstracts. 2013;31:P258.
27. Srirangalingam U, Khan F, Gunganah K, et al. SDHB surveillance regime: a single UK institution experience. Endocrine Abstracts. 2014;34:P188.
28. Almeida MQ, Stratakis CA. Solid tumors associated with multiple endocrine neoplasias. Cancer Genet Cytogenet. 2010;203:30-36.
29. Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44:328-333.
30. th Annual Meeting of European Network for the Study of Adrenal Tumors ENSAT; 2013;Abstract Book:P29.
31. Gill AJ, Toon CW, Clarkson A, et al. Succinate dehydrogenase deficiency is rare in pituitary adenomas. Am J Surg Pathol. 2014;38:560-566.
32. Papathomas TG, Gaal J, Corssmit EP, et al. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol. 2014;170:1-12.
33. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827-836.
34. Majumdar S, Friedrich CA, Koch CA, Megason GC, Fratkin JD, Moll GW. Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma. Pediatr Blood Cancer. 2010;54:473-475.
35. Lopez-Jimenez E, de Campos JM, Kusak EM, et al. SDHC mutation in an elderly patient without familial antecedents. Clin Endocrinol (Oxf). 2008;69:906-910.
36. Varsavsky M, Sebastian-Ochoa A, Torres Vela E. Coexistence of a pituitary macroadenoma and multicentric paraganglioma: a strange coincidence. Endocrinol Nutr. 2013;60:154-156.
37. Xekouki P, Pacak K, Almeida M, et al. Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? J Clin Endocrinol Metab. 2012;97:E357-E366.
38. Brauer VF, Scholz GH, Neumann S, Lohmann T, Paschke R, Koch CA. RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed? Endocr Pract. 2004;10:5-9.
39. Saito T, Miura D, Taguchi M, Takeshita A, Miyakawa M, Takeuchi Y. Coincidence of multiple endocrine neoplasia type 2A with acromegaly. Am J Med Sci. 2010;340:329-331.
40. Heinlen JE, Buethe DD, Culkin DJ, Slobodov G. Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma. ISRN Oncol. 2011;2011:732452.
41. th International Workshop on Multiple Endocrine Neoplasia Final Program and Abstract Book: 77; P43.
42. Klijanienko J, Lagace R. Particular aspects. In: Klijanienko J, Lagace R, eds. Soft Tissue Tumors: A Multidisciplinary Decisional Diagnostic Approach. Hoboken, NJ: John Wiley Blackwell; 2011:121-411.
43. Necchi V, Sommi P, Vanoli A, Manca R, Ricci V, Solcia E. Proteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study. PLoS One. 2011;6:e21317.
44. Ishikawa T, Miyaishi S, Tachibana T, Ishizu H, Zhu BL, Maeda H. Fatal hypothermia related vacuolation of hormone-producing cells in the anterior pituitary. Leg Med (Tokyo). 2004;6:157-163.
45. Doberentz E, Preuss-Wossner J, Kuchelmeister K, Madea B. Histological examination of the pituitary glands in cases of fatal hypothermia. Forensic Sci Int. 2011;207:46-49.
46. Kurelac I, MacKay A, Lambros MB, et al. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas. Hum Mol Genet. 2013;22:226-238.
47. Housley SL, Lindsay RS, Young B, et al. Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene. Histopathology. 2010;56:405-408.
48. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37:1469-1489.
49. Horoupian DS. Large mitochondria in a pituitary adenoma with hyperprolactinemia. Cancer. 1980;46:537-542.
50. Horvath E, Kovacs K, Singer W, et al. Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases. Cancer. 1981;47:761-771.
51. Kroemer G. Mitochondria in cancer. Oncogene. 2006;25:4630-4632.
52. Zhan X, Desiderio DM. Signaling pathway networks mined from human pituitary adenoma proteomics data. BMC Med Genomics. 2010;3:13.